What Challenges Exist in Nanotechnology-Based Immunosuppressive Drug Delivery?
Despite the potential benefits, several challenges need to be addressed: - Toxicity: The long-term toxicity of nanomaterials is a significant concern and requires thorough investigation. - Manufacturing: The large-scale production of nanocarriers with consistent quality is challenging. - Regulatory Hurdles: Regulatory frameworks for nanomedicine are still evolving, posing challenges for clinical translation. - Stability: Ensuring the stability of nanocarriers in biological environments is crucial for their effectiveness.
